20 Countries with the Highest Cancer Survival Rates in the World

Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?

Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Engineering a Cool Career in Biotech - and Volunteering Along the Way

Evidence Supports Sequencing As First-Line Rare Disease Diagnostic

Microsoft-Backed Rubrik Seeks Up to $713 Million in IPO

European Commission approves Illumina’s proposed Grail split

Rubrik Is Seeking IPO of as Much as $713 Million

Illumina's planned divestment of GRAIL approved by the European Commission

UPDATE 1-EU approves Illumina's plan to divest cancer test maker Grail

EU approves Illumina's plan to divest cancer test maker Grail

EU approves Illumina's plan to divest cancer test maker Grail

Search for Cancer Blood Test Continues Despite Illumina-Grail Deal’s Failure

Illumina CFO steps down amid executive shakeup

UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed

Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor

Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed

Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer